Loading organizations...
§ Private Profile · Stockholm, Stockholms Lan, Sweden
Biopharmaceutical company developing novel medicines for fibrotic diseases.
Tribune Therapeutics has raised $27.0M across 1 funding round.
Tribune Therapeutics has raised $27.0M in total across 1 funding round.
Tribune Therapeutics has raised $27.0M in total across 1 funding round.
Tribune Therapeutics's investors include LifeArc.
Tribune Therapeutics has raised $27.0M across 1 funding round. Most recently, it raised $27.0M Series A in March 2025.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Mar 26, 2025 | $27M Series A | LifeArc | — | Announced |